[Organ Interactions: Heart and kidney]

Area of Science:

• Cardiology
• Nephrology
• Cardiorenal Medicine

Background:

• The heart and kidney exhibit intricate interactions, where dysfunction in one organ significantly affects the other.
• Established classification systems like NYHA for heart failure and KDIGO for kidney disease are applicable to cardiorenal systems.
• Cardiorenal syndromes represent a complex clinical entity necessitating a multidisciplinary approach to management.

Purpose of the Study:

• To highlight the clinical relevance of cardiorenal interactions.
• To emphasize the utility of existing and specific classification systems for cardiorenal syndromes.
• To discuss the pathophysiology and management strategies for cardiorenal syndromes.

Main Methods:

• Review of existing literature on cardiorenal interactions and syndromes.
• Discussion of pathophysiological mechanisms, including the role of the renin-angiotensin-aldosteron-system (RAAS).
• Exploration of diagnostic and therapeutic approaches, such as the furosemide stress test and fluid management.

Main Results:

• The renin-angiotensin-aldosteron-system (RAAS) plays a critical role in cardiorenal syndrome pathophysiology, leading to salt/water retention and vasoconstriction.
• General cardiovascular disease prevention strategies are beneficial for cardiorenal syndromes.
• Balanced intravascular volume is crucial; negative fluid balance can improve renal perfusion and function, though initial preload reduction may transiently impact renal function.

Conclusions:

• Cardiorenal syndromes require an interdisciplinary team approach for optimal patient outcomes.
• Management should focus on controlling hypertension, diabetes, and maintaining appropriate fluid balance.
• Therapeutic interventions like RAAS blockers are important for preventing cardiac remodeling and managing cardiorenal dysfunction.